The A-Z of bacterial translation inhibitors - PubMed (original) (raw)
Review
. 2009 Nov-Dec;44(6):393-433.
doi: 10.3109/10409230903307311.
Affiliations
- PMID: 19929179
- DOI: 10.3109/10409230903307311
Review
The A-Z of bacterial translation inhibitors
Daniel N Wilson. Crit Rev Biochem Mol Biol. 2009 Nov-Dec.
Abstract
Protein synthesis is one of the major targets in the cell for antibiotics. This review endeavors to provide a comprehensive "post-ribosome structure" A-Z of the huge diversity of antibiotics that target the bacterial translation apparatus, with an emphasis on correlating the vast wealth of biochemical data with more recently available ribosome structures, in order to understand function. The binding site, mechanism of action, and modes of resistance for 26 different classes of protein synthesis inhibitors are presented, ranging from ABT-773 to Zyvox. In addition to improving our understanding of the process of translation, insight into the mechanism of action of antibiotics is essential to the development of novel and more effective antimicrobial agents to combat emerging bacterial resistance to many clinically-relevant drugs.
Similar articles
- Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development.
Arenz S, Wilson DN. Arenz S, et al. Mol Cell. 2016 Jan 7;61(1):3-14. doi: 10.1016/j.molcel.2015.10.019. Epub 2015 Nov 12. Mol Cell. 2016. PMID: 26585390 Review. - Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity - lessons to be learned.
Böttger EC. Böttger EC. Cell Mol Life Sci. 2007 Apr;64(7-8):791-5. doi: 10.1007/s00018-007-6431-5. Cell Mol Life Sci. 2007. PMID: 17429579 Free PMC article. Review. No abstract available. - Putting the antibiotics chloramphenicol and linezolid into context.
Crowe-McAuliffe C, Wilson DN. Crowe-McAuliffe C, et al. Nat Struct Mol Biol. 2022 Feb;29(2):79-81. doi: 10.1038/s41594-022-00725-7. Nat Struct Mol Biol. 2022. PMID: 35165457 No abstract available. - Dissecting the Nucleoside Antibiotics as Universal Translation Inhibitors.
Nelli MR, Heitmeier KN, Looper RE. Nelli MR, et al. Acc Chem Res. 2021 Jul 6;54(13):2798-2811. doi: 10.1021/acs.accounts.1c00221. Epub 2021 Jun 21. Acc Chem Res. 2021. PMID: 34152729 - Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.
Lin J, Zhou D, Steitz TA, Polikanov YS, Gagnon MG. Lin J, et al. Annu Rev Biochem. 2018 Jun 20;87:451-478. doi: 10.1146/annurev-biochem-062917-011942. Epub 2018 Mar 23. Annu Rev Biochem. 2018. PMID: 29570352 Free PMC article. Review.
Cited by
- A Broad Spectrum Lasso Peptide Antibiotic Targeting the Bacterial Ribosome.
Wright G, Jangra M, Travin D, Aleksandrova E, Kaur M, Darwish L, Koteva K, Klepacki D, Wang W, Tiffany M, Sokaribo A, Coombes B, Vázquez-Laslop N, Polikanov Y, Mankin A. Wright G, et al. Res Sq [Preprint]. 2024 Sep 16:rs.3.rs-5058118. doi: 10.21203/rs.3.rs-5058118/v1. Res Sq. 2024. PMID: 39372947 Free PMC article. Preprint. - Hibernating ribosomes as drug targets?
Ekemezie CL, Melnikov SV. Ekemezie CL, et al. Front Microbiol. 2024 Jul 29;15:1436579. doi: 10.3389/fmicb.2024.1436579. eCollection 2024. Front Microbiol. 2024. PMID: 39135874 Free PMC article. Review. - Berberine analog of chloramphenicol exhibits a distinct mode of action and unveils ribosome plasticity.
Batool Z, Pavlova JA, Paranjpe MN, Tereshchenkov AG, Lukianov DA, Osterman IA, Bogdanov AA, Sumbatyan NV, Polikanov YS. Batool Z, et al. Structure. 2024 Sep 5;32(9):1429-1442.e6. doi: 10.1016/j.str.2024.06.013. Epub 2024 Jul 16. Structure. 2024. PMID: 39019034 - Development of a luciferase-based Gram-positive bacterial reporter system for the characterization of antimicrobial agents.
Lam NM, Tsang TF, Qu J, Tsang MW, Tao Y, Kan CH, Zou Q, Chan KH, Chu AJ, Ma C, Yang X. Lam NM, et al. Appl Environ Microbiol. 2024 Aug 21;90(8):e0071724. doi: 10.1128/aem.00717-24. Epub 2024 Jul 17. Appl Environ Microbiol. 2024. PMID: 39016615 - Structural basis of Cfr-mediated antimicrobial resistance and mechanisms to evade it.
Aleksandrova EV, Wu KJY, Tresco BIC, Syroegin EA, Killeavy EE, Balasanyants SM, Svetlov MS, Gregory ST, Atkinson GC, Myers AG, Polikanov YS. Aleksandrova EV, et al. Nat Chem Biol. 2024 Jul;20(7):867-876. doi: 10.1038/s41589-023-01525-w. Epub 2024 Jan 18. Nat Chem Biol. 2024. PMID: 38238495
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical